Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,837 | 856 | 99.9% |
| Education | $11.02 | 2 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $2,139 | 112 | $0 (2024) |
| Novo Nordisk Inc | $1,482 | 116 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,128 | 57 | $0 (2024) |
| Lilly USA, LLC | $966.14 | 71 | $0 (2024) |
| PFIZER INC. | $809.46 | 75 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $768.65 | 58 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $731.58 | 54 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $538.96 | 35 | $0 (2024) |
| Amgen Inc. | $518.60 | 34 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $454.23 | 23 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,728 | 159 | ABBVIE INC. ($490.20) |
| 2023 | $3,206 | 186 | AbbVie Inc. ($1,100) |
| 2022 | $2,578 | 161 | ABBVIE INC. ($361.68) |
| 2021 | $661.48 | 46 | AbbVie Inc. ($187.13) |
| 2020 | $485.31 | 31 | AstraZeneca Pharmaceuticals LP ($110.94) |
| 2019 | $999.74 | 85 | PFIZER INC. ($181.64) |
| 2018 | $982.01 | 90 | Novo Nordisk Inc ($186.88) |
| 2017 | $1,208 | 100 | AstraZeneca Pharmaceuticals LP ($173.55) |
All Payment Transactions
858 individual payment records from CMS Open Payments — Page 1 of 35
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $26.71 | General |
| Category: SCHIZOPHRENIA | ||||||
| 12/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: PAIN | ||||||
| 12/09/2024 | AIMMUNE THERAPEUTICS, INC. | ZENPEP (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: ENDOCRINE PANCREATIC INSUFFICIENCY | ||||||
| 12/05/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $10.74 | General |
| Category: Diabetes | ||||||
| 12/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $2.64 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Biogen, Inc. | SKYCLARYS (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Neurology | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: PAIN | ||||||
| 11/25/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $24.99 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/20/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.14 | General |
| Category: Diabetes | ||||||
| 11/19/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: NEUROSCIENCE | ||||||
| 11/18/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Diabetes | ||||||
| 11/15/2024 | Vanda Pharmaceuticals Inc. | FANAPT (Drug) | Food and Beverage | In-kind items and services | $18.60 | General |
| Category: SCHIZOPHRENIA | ||||||
| 11/14/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Inflammation | ||||||
| 11/14/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $5.33 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.84 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/05/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.25 | General |
| Category: Cardiovascular | ||||||
| 11/04/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $11.42 | General |
| Category: PAIN | ||||||
| 11/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.20 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $14.29 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.93 | General |
| Category: PAIN | ||||||
| 10/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.95 | General |
| Category: Diabetes | ||||||
| 10/17/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $18.52 | General |
| Category: Inflammation | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 804 | 1,332 | $332,347 | $89,956 |
| 2022 | 18 | 990 | 1,585 | $318,616 | $87,543 |
| 2021 | 18 | 1,079 | 1,681 | $340,188 | $97,178 |
| 2020 | 16 | 985 | 1,440 | $284,859 | $72,393 |
All Medicare Procedures & Services
65 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 245 | 609 | $203,406 | $46,178 | 22.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 188 | 188 | $64,672 | $22,681 | 35.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 127 | $28,448 | $7,590 | 26.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 54 | 61 | $11,163 | $4,569 | 40.9% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 15 | 15 | $6,120 | $4,229 | 69.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 57 | 64 | $5,248 | $1,879 | 35.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 18 | 22 | $3,960 | $864.38 | 21.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $1,968 | $704.64 | 35.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 47 | 53 | $1,060 | $437.15 | 41.2% |
| 85610 | Blood test, clotting time | Office | 2023 | 14 | 81 | $2,430 | $333.50 | 13.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 24 | 28 | $1,988 | $274.85 | 13.8% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 18 | 24 | $1,848 | $212.20 | 11.5% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 19 | 36 | $36.00 | $2.97 | 8.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 220 | 523 | $174,682 | $41,209 | 23.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 192 | 192 | $66,048 | $23,919 | 36.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 79 | 112 | $25,088 | $6,686 | 26.6% |
| 90670 | Pneumococcal vaccine, 13-valent | Office | 2022 | 12 | 12 | $3,960 | $2,998 | 75.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 35 | 35 | $6,405 | $2,447 | 38.2% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2022 | 17 | 17 | $4,250 | $2,245 | 52.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 22 | 22 | $11,198 | $2,102 | 18.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 56 | 56 | $4,592 | $1,567 | 34.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 181 | 294 | $5,880 | $863.23 | 14.7% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 29 | 29 | $2,378 | $817.93 | 34.4% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $2,013 | $753.94 | 37.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 20 | 21 | $3,780 | $732.20 | 19.4% |
About Dr. Basem Doss, MD
Dr. Basem Doss, MD is a Internal Medicine healthcare provider based in Niles, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2005. The National Provider Identifier (NPI) number assigned to this provider is 1588650113.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Basem Doss, MD has received a total of $12,848 in payments from pharmaceutical and medical device companies, with $2,728 received in 2024. These payments were reported across 858 transactions from 45 companies. The most common payment nature is "Food and Beverage" ($12,837).
As a Medicare-enrolled provider, Doss has provided services to 3,858 Medicare beneficiaries, totaling 6,038 services with total Medicare billing of $347,069. Data is available for 4 years (2020–2023), covering 65 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Internal Medicine
- Location Niles, OH
- Active Since 09/20/2005
- Last Updated 12/30/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1588650113
Products in Payments
- VRAYLAR (Drug) $1,569
- FARXIGA (Drug) $720.96
- XARELTO (Drug) $698.09
- XIFAXAN (Drug) $677.57
- MOUNJARO (Drug) $591.89
- Ozempic (Drug) $557.60
- Otezla (Drug) $463.97
- Kerendia (Drug) $454.23
- QULIPTA (Drug) $411.21
- JARDIANCE (Drug) $346.01
- NURTEC ODT (Drug) $307.46
- Rybelsus (Drug) $297.40
- ELIQUIS (Drug) $293.47
- BREZTRI (Drug) $282.72
- TRELEGY ELLIPTA (Drug) $261.29
- UBRELVY (Drug) $255.70
- Saxenda (Drug) $247.33
- REXULTI (Drug) $246.64
- ENTRESTO (Drug) $245.75
- TRADJENTA (Drug) $231.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Niles
Dr. Ramona Sheth, M.d.,, M.D.,
Internal Medicine — Payments: $21,982
Dr. Sanjay Sheth, M.d, M.D
Internal Medicine — Payments: $17,755
Dr. Peter Sargon, M.d, M.D
Internal Medicine — Payments: $7,824
Dr. Bahaa Awadalla, M.d, M.D
Internal Medicine — Payments: $7,824
Dr. Heba Mikhail, M.d, M.D
Internal Medicine — Payments: $7,463
Gail Herman, M.d, M.D
Internal Medicine — Payments: $6,453